Long-term outcome in patients with apical hypertrophic cardiomyopathy
Maria J. Eriksson, MD, PhD*,
Brian Sonnenberg, MD*,
Anna Woo, MD, FACC*,
Paul Rakowski*,
Thomas G. Parker, MD, FACC*,
E. Douglas Wigle, MD, FACC* and
Harry Rakowski, MD, FACC*,*
* Division of Cardiology, University Hospital Network Toronto General Hospital, University of Toronto, Toronto, Canada
View larger version (18K):
[in a new window]
|
Figure 1 Kaplan-Meier plot of overall survival since initial presentation of 105 patients with apical hypertrophic cardiomyopathy (ApHCM) (solid line) in comparison to an age- and gender-matched Ontario population (Ontario) (dotted line). Probability of survival ± 1 standard error at 15, 20 and 25 years of follow-up are shown.
|
|
View larger version (17K):
[in a new window]
|
Figure 2 Kaplan-Meier analysis of freedom from major cardiac morbidity with probability of event-free survival ± 1 standard error at 5, 10, 15, 20 and 25 years of follow-up are shown.
|
|
|
